Comparison of conventional dose steroid treatment and high dose steroid treatment as run-in regime for splenectomy in immune thrombocytopenic purpura (ITP)

被引:6
作者
Bilgir, Oktay [1 ]
Bilgir, Ferda [2 ]
Kebapcilar, Levent [1 ]
Bozkaya, Giray [3 ]
Calan, Mehmet [1 ]
Kirbiyik, Halil [1 ]
Avci, Meltem [4 ]
Sari, Ismail [1 ]
Yuksel, Arif [1 ]
Isikyakar, Tolgay [1 ]
机构
[1] Izmir Bozyaka Res & Training Hosp, Dept Internal Med, TR-35380 Izmir, Turkey
[2] Buca State Hosp, Dept Internal Med, Izmir, Turkey
[3] Izmir Bozyaka Res & Training Hosp, Dept Biochem, TR-35380 Izmir, Turkey
[4] Izmir Bozyaka Res & Training Hosp, Dept Infect Dis, TR-35380 Izmir, Turkey
关键词
Splenectomy; Run-in regime; High dose steroid; ITP; ADULT PATIENTS; ANTI-D; DEXAMETHASONE; EFFICACY;
D O I
10.1016/j.transci.2011.04.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Splenectomy is a treatment procedure for ITP which is being used for more that 50 years and is still considered as the best option for the treatment of the condition. The facts that frequent monitoring is not required and that medical treatment is not indicated following splenectomy in most cases are among the major advantages of the procedure. Aim of the study: To compare the conventional dose steroid and high dose steroid treatments as run-in regime for splenectomy in patients diagnosed with ITP. Methods: The conventional dose steroid (1 mg/kg, n = 20) and high dose steroid treatments (30 mg/kg, n = 30) were applied to 50 cases with ITP between 1998 and 2008 in our clinic. Results: High dose steroid produced higher platelet count on days 3, 5, and 7 compared to conventional dose steroid. There were no differences between the groups in terms of adverse effects. Treatments were discontinued after the operation by rapidly reducing the dose. Postoperative values regarding response to splenectomy were comparable in both groups. Conclusions: Both higher and earlier responses obtained with high dose steroid may be significant in reducing hospitalization period of patients and eliminating life-threatening platelet values within the shortest time possible. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:239 / 242
页数:4
相关论文
共 22 条
  • [1] Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with idiopathic thrombocytopenic purpura
    Alpdogan, Ö
    Budak-Alpdogan, T
    Ratip, S
    Firatli-Tuglular, T
    Tanriverdi, S
    Karti, S
    Bayik, M
    Akoglu, T
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (04) : 1061 - 1063
  • [2] RESPONSE OF RESISTANT IDIOPATHIC THROMBOCYTOPENIC PURPURA TO PULSED HIGH-DOSE DEXAMETHASONE THERAPY
    ANDERSEN, JC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (22) : 1560 - 1564
  • [3] Systematic review: Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura
    Arnold, Donald M.
    Dentali, Francesco
    Crowther, Mark A.
    Meyer, Ralph M.
    Cook, Richard J.
    Sigouin, Christopher
    Fraser, Graeme A.
    Lim, Wendy
    Kelton, John G.
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 146 (01) : 25 - W5
  • [4] BUSSEL J, 2007, HAEMATOLOGICA, V92, P1814
  • [5] Medical progress: Immune thrombocytopenic purpura.
    Cines, DB
    Blanchette, VS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (13) : 995 - 1008
  • [6] How I treat idiopathic thrombocytopenic purpura (ITP)
    Cines, DB
    Bussel, JB
    [J]. BLOOD, 2005, 106 (07) : 2244 - 2251
  • [7] Recombinant Factor VIIA for refractive haemorrhage in autoimmune idiopathic thrombocytopenic purpura
    Culic, S
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (05) : 909 - 910
  • [8] IDIOPATHIC AND SECONDARY THROMBOCYTOPENIC PURPURA - CLINICAL STUDY AND EVALUATION OF 381 CASES OVER A PERIOD OF 28 YEARS
    DOAN, CA
    BOURONCLE, BA
    WISEMAN, BK
    [J]. ANNALS OF INTERNAL MEDICINE, 1960, 53 (05) : 861 - 876
  • [9] Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology
    George, JN
    Woolf, SH
    Raskob, GE
    Wasser, JS
    Aledort, LM
    Ballem, PJ
    Blanchette, VS
    Bussel, JB
    Cines, DB
    Kelton, JG
    Lichtin, AE
    McMillan, R
    Okerbloom, JA
    Regan, DH
    Warrier, I
    [J]. BLOOD, 1996, 88 (01) : 3 - 40
  • [10] Godeau B, 2006, BLOOD, V108, p145A